Mike Sharma, MD, MSc, FRCPC - Deepening the Dialogue on the Latest Data for Factor XIa Inhibition: Is It Time to Shift the Paradigm in Secondary Stroke Prevention?

For the complete activity, including supporting material, please visit https://www.peervoice.com/GWR860. Presented by Mike Sharma, MD, MSc, FRCPC; Xin Cheng, MD, PhD; Emiliya Melkumova, MD; and Roland Veltkamp, MD. Learning Objectives: Evaluate efficacy and safety outcomes for Factor XIa (FXIa) inhibitors in the prevention of ischemic stroke following an acute non-cardioembolic ischemic stroke (NCIS) or high-risk transient ischemic attack (TIA); Identify patient-specific characteristics that may influence the efficacy or safety of FXIa inhibitors for secondary stroke prevention (SSP); Apply current guideline-directed best practices for the management of acute NCIS or high-risk TIA.

Listen